About
Convelo Therapeutics develops patented therapies aimed at enhancing remyelination in the central nervous system to treat multiple sclerosis by promoting natural repair and restoration.
Explore Convelo Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.